CSIMarket
 
Sagimet Biosciences inc   (NASDAQ: SGMT)
 

Sagimet Biosciences Inc's Suppliers Performance

SGMT's Supply Chain




 
SGMT Costs vs Sales of Suppliers Growth

• More on SGMT Suppliers






Sagimet Biosciences Inc's Comment on Supply Chain


The company sources raw materials, active pharmaceutical ingredients (APIs), and finished products for denifanstat, TVB-3567, and resmetirom from multiple suppliers and contract manufacturing organizations (CMOs). Four CMOs located in Europe, the United States, and China, along with their license partner Ascletis, produce drug substances. For drug products, the company utilizes two CMOs in the United States and China, as well as Ascletis. In December 2025, the company entered into a license agreement with Assia Chemical Industries Ltd., operating as TAPI Technology & API Services (TAPI), a subsidiary of Teva Pharmaceutical Industries Ltd., granting TAPI a global, exclusive license to certain intellectual property rights related to resmetirom API for evaluation and potential further development. All CMOs operate under current Good Manufacturing Practice (cGMP) requirements and applicable laws and regulations.

Sagimet Biosciences Inc's Comment on Supply Chain


The company sources raw materials, active pharmaceutical ingredients (APIs), and finished products for denifanstat, TVB-3567, and resmetirom from multiple suppliers and contract manufacturing organizations (CMOs). Four CMOs located in Europe, the United States, and China, along with their license partner Ascletis, produce drug substances. For drug products, the company utilizes two CMOs in the United States and China, as well as Ascletis. In December 2025, the company entered into a license agreement with Assia Chemical Industries Ltd., operating as TAPI Technology & API Services (TAPI), a subsidiary of Teva Pharmaceutical Industries Ltd., granting TAPI a global, exclusive license to certain intellectual property rights related to resmetirom API for evaluation and potential further development. All CMOs operate under current Good Manufacturing Practice (cGMP) requirements and applicable laws and regulations.







SGMT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Sagimet Biosciences inc 490.78 0.00 -47.08 16
SUBTOTAL 0.00 0.00 0.00 -


Sources: Sagimet Biosciences inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Sagimet Biosciences inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.